Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03072095
Other study ID # 826576
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 17, 2017
Est. completion date November 3, 2017

Study information

Verified date February 2019
Source University of Pennsylvania
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This randomized controlled pilot study at the Health Annex, Family Practice & Counseling Network (FPCN), a community clinic in Southwest Philadelphia, aimed at providing data on the feasibility of a mailed FIT approach to CRC screening in a community health setting, and how patients respond to text messaging and behavioral economic engagement incentives.


Description:

This is a single-center RCT at the Family Practice & Counseling Network (FPCN), a community clinic in Southwest Philadelphia with 320 eligible subjects between the ages of 50-74 randomized to two study arms:

1. text messaging outreach (text)

2. text messaging outreach with lottery for 1/5 chance to win a financial incentive (text + lottery).

Findings will provide data on the feasibility of this mailed FIT approach in a community health setting, and how patients respond to text messaging and behavioral economic engagement incentives.


Recruitment information / eligibility

Status Completed
Enrollment 281
Est. completion date November 3, 2017
Est. primary completion date August 3, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 50 Years to 74 Years
Eligibility Inclusion Criteria:

1. Between 50 and 74 years old

2. Has active medical insurance

3. Has had had at least one visit at Health Annex in the prior 12 months (at time of chart review)

4. Due for CRC screening (no colonoscopy in last 10 years, sigmoidoscopy in last 5 years, or stool testing in last 1 year)

5. Asymptomatic for CRC

Exclusion Criteria:

1. Has had prior colonoscopy within 10 years, sigmoidoscopy within 5 years, and FOBT/FIT within twelve months of the chart review (we will exclude patients who self-report undergoing any of the above procedures)

2. Has a history of CRC

3. Has a history of other GI cancer

4. Has history of confirmed Inflammatory Bowel Disease (IBD) (e.g. Crohns disease, ulcerative colitis)

5. Has a history of colon polyps

6. Has had a colectomy

7. Has a first-degree relative that has been diagnosed with CRC

8. Has been diagnosed with Lynch Syndrome (i.e. HNPCC)

9. Has been diagnosed with Familial Adenomatous Polyposis (FAP).

10. Has iron deficiency anemia

11. Has recent history of lower GI bleeding

12. Has metastatic (Stage IV) blood or solid tumor cancer

13. Has end stage renal disease

14. Has had congestive heart failure

15. Has dementia

16. Has liver cirrhosis

17. Has any other condition that, in the opinion of the investigator, excludes the patient from participating in this study

18. Does not use a mobile phone enabled to send and receive text messages

Study Design


Intervention

Behavioral:
Text-only
Subjects will receive a text communication indicating they are overdue for colon cancer screening with the option to elect to receive a free, at-home FIT kit.
Text + Lottery
Subjects will receive a text communication indicating they are overdue for colon cancer screening with the option to elect to receive a free, at-home FIT kit and a 1 in 5 chance to win a $100 gift card for completing the kit.

Locations

Country Name City State
United States Family Practice & Counseling Network - Health Annex Philadelphia Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
University of Pennsylvania

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary FIT completion within 3 months The percentage of participants who successfully complete the FIT 3 months
Secondary Response to text-based CRC screening outreach The percentage of people who respond to text message 3 months
See also
  Status Clinical Trial Phase
Completed NCT03068052 - Behavioral Economic Incentives and Cancer Health Risk Assessment N/A
Active, not recruiting NCT03446157 - Palbociclib and Cetuximab in Metastatic Colorectal Cancer Phase 2
Recruiting NCT05955196 - Test of CD47-SIRPĪ± Inhibitors on the Immune Microenvironment Colon Cancer
Completed NCT01287130 - AZD6244 With Cetuximab for Solid Tumors and Colorectal Cancer Phase 1
Active, not recruiting NCT05179837 - Endoscopic Optical Coherence Tomography for Screening and Diagnosis of Colorectal Precancerous and Malignant Polyps N/A
Completed NCT02929186 - Opt-In Versus Opt-Out for Colorectal Cancer Screening Outreach N/A
Completed NCT02660671 - Behavioral Economic Approaches to Increase Colorectal Cancer Screening N/A